168 related articles for article (PubMed ID: 33585200)
21. Expression of the heparan sulfate 6-O-endosulfatases, Sulf1 and Sulf2, in the avian and mammalian inner ear suggests a role for sulfation during inner ear development.
Freeman SD; Keino-Masu K; Masu M; Ladher RK
Dev Dyn; 2015 Feb; 244(2):168-80. PubMed ID: 25370455
[TBL] [Abstract][Full Text] [Related]
22. Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma.
Yi B; Qiu Y; Ji W; Wei M; Liu C; Peng Z; Zhang Y; Quan Z; Tang Z; Su C
Cancer Lett; 2016 Oct; 381(2):349-58. PubMed ID: 27502167
[TBL] [Abstract][Full Text] [Related]
23. Dynamic expression patterns of 6-O endosulfatases during zebrafish development suggest a subfunctionalisation event for sulf2.
Gorsi B; Whelan S; Stringer SE
Dev Dyn; 2010 Dec; 239(12):3312-23. PubMed ID: 20981828
[TBL] [Abstract][Full Text] [Related]
24. Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis.
Lemjabbar-Alaoui H; van Zante A; Singer MS; Xue Q; Wang YQ; Tsay D; He B; Jablons DM; Rosen SD
Oncogene; 2010 Feb; 29(5):635-46. PubMed ID: 19855436
[TBL] [Abstract][Full Text] [Related]
25. Sulfatase-2: a prognostic biomarker and candidate therapeutic target in patients with pancreatic ductal adenocarcinoma.
Alhasan SF; Haugk B; Ogle LF; Beale GS; Long A; Burt AD; Tiniakos D; Televantou D; Coxon F; Newell DR; Charnley R; Reeves HL
Br J Cancer; 2016 Sep; 115(7):797-804. PubMed ID: 27560551
[TBL] [Abstract][Full Text] [Related]
26. Unraveling Heparan Sulfate Proteoglycan Binding Motif for Cancer Cell Selectivity.
Brunetti J; Riolo G; Depau L; Mandarini E; Bernini A; Karousou E; Passi A; Pini A; Bracci L; Falciani C
Front Oncol; 2019; 9():843. PubMed ID: 31620357
[TBL] [Abstract][Full Text] [Related]
27. SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells.
Vicente CM; Lima MA; Nader HB; Toma L
J Exp Clin Cancer Res; 2015 Mar; 34(1):25. PubMed ID: 25887999
[TBL] [Abstract][Full Text] [Related]
28. Sulfatase 2 Modulates Fate Change from Motor Neurons to Oligodendrocyte Precursor Cells through Coordinated Regulation of Shh Signaling with Sulfatase 1.
Jiang W; Ishino Y; Hashimoto H; Keino-Masu K; Masu M; Uchimura K; Kadomatsu K; Yoshimura T; Ikenaka K
Dev Neurosci; 2017; 39(5):361-374. PubMed ID: 28490013
[TBL] [Abstract][Full Text] [Related]
29. QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling.
Ai X; Do AT; Lozynska O; Kusche-Gullberg M; Lindahl U; Emerson CP
J Cell Biol; 2003 Jul; 162(2):341-51. PubMed ID: 12860968
[TBL] [Abstract][Full Text] [Related]
30. Sulfatase 2-Induced Cancer-Associated Fibroblasts Promote Hepatocellular Carcinoma Progression via Inhibition of Apoptosis and Induction of Epithelial-to-Mesenchymal Transition.
Wang C; Shang C; Gai X; Song T; Han S; Liu Q; Zheng X
Front Cell Dev Biol; 2021; 9():631931. PubMed ID: 33889573
[TBL] [Abstract][Full Text] [Related]
31. Targeting Heparan Sulfate Proteoglycans and their Modifying Enzymes to Enhance Anticancer Chemotherapy Efficacy and Overcome Drug Resistance.
Lanzi C; Zaffaroni N; Cassinelli G
Curr Med Chem; 2017; 24(26):2860-2886. PubMed ID: 28215163
[TBL] [Abstract][Full Text] [Related]
32. Glycomics analysis of mammalian heparan sulfates modified by the human extracellular sulfatase HSulf2.
Staples GO; Shi X; Zaia J
PLoS One; 2011 Feb; 6(2):e16689. PubMed ID: 21347431
[TBL] [Abstract][Full Text] [Related]
33. 6-O-endosulfatases in tumor metastasis: heparan sulfate proteoglycans modification and potential therapeutic targets.
Han M; Zhu H; Chen X; Luo X
Am J Cancer Res; 2024; 14(2):897-916. PubMed ID: 38455409
[TBL] [Abstract][Full Text] [Related]
34. Trisaccharide Sulfate and Its Sulfonamide as an Effective Substrate and Inhibitor of Human Endo-
Chiu LT; Sabbavarapu NM; Lin WC; Fan CY; Wu CC; Cheng TR; Wong CH; Hung SC
J Am Chem Soc; 2020 Mar; 142(11):5282-5292. PubMed ID: 32083852
[TBL] [Abstract][Full Text] [Related]
35. Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteins.
Chen K; Liu ML; Schaffer L; Li M; Boden G; Wu X; Williams KJ
Hepatology; 2010 Dec; 52(6):1957-67. PubMed ID: 21049473
[TBL] [Abstract][Full Text] [Related]
36. Human extracellular sulfatases use a dual mechanism for regulation of growth factor interactions with heparan sulfate proteoglycans.
Timm BM; Follmar JL; Porell RN; Glass K; Thacker BE; Glass CA; Godula K
bioRxiv; 2023 Nov; ():. PubMed ID: 38045270
[TBL] [Abstract][Full Text] [Related]
37. Method development and analysis of free HS and HS in proteoglycans from pre- and postmenopausal women: evidence for biosynthetic pathway changes in sulfotransferase and sulfatase enzymes.
Wei W; Miller RL; Leary JA
Anal Chem; 2013 Jun; 85(12):5917-23. PubMed ID: 23659730
[TBL] [Abstract][Full Text] [Related]
38. The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.
Hammond E; Khurana A; Shridhar V; Dredge K
Front Oncol; 2014; 4():195. PubMed ID: 25105093
[TBL] [Abstract][Full Text] [Related]
39. Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity.
Lamanna WC; Baldwin RJ; Padva M; Kalus I; Ten Dam G; van Kuppevelt TH; Gallagher JT; von Figura K; Dierks T; Merry CL
Biochem J; 2006 Nov; 400(1):63-73. PubMed ID: 16901266
[TBL] [Abstract][Full Text] [Related]
40. Receptor tyrosine kinases and heparan sulfate proteoglycans: Interplay providing anticancer targeting strategies and new therapeutic opportunities.
Lanzi C; Cassinelli G
Biochem Pharmacol; 2020 Aug; 178():114084. PubMed ID: 32526230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
